Intravenous Nicotinamide Riboside Administration Has a Cardioprotective Effect in Chronic Doxorubicin-Induced Cardiomyopathy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous Nicotinamide Riboside Administration Has a Cardioprotective Effect in Chronic Doxorubicin-Induced Cardiomyopathy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 21, Pages 13096
Publisher
MDPI AG
Online
2022-10-30
DOI
10.3390/ijms232113096
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice
- (2022) Mi-Bo Kim et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Nicotinamide Riboside Supplementation to Suckling Male Mice Improves Lipid and Energy Metabolism in Skeletal Muscle and Liver in Adulthood
- (2022) Alba Serrano et al. Nutrients
- Short term nicotinamide riboside treatment improves muscle quality and function in mice as well as increases cellular energetics and differentiating capacity of myogenic progenitors
- (2021) Kenneth Ladd Seldeen et al. NUTRITION
- NMRK2 Gene Is Upregulated in Dilated Cardiomyopathy and Required for Cardiac Function and NAD Levels during Aging
- (2021) Cynthia Tannous et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies
- (2021) David Dahlgren et al. Frontiers in Pharmacology
- Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician
- (2021) Ekaterina Yu Podyacheva et al. Frontiers in Pharmacology
- Microbiota modulate Doxorubicin induced cardiotoxicity
- (2021) Lulu An et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects
- (2021) Ekaterina Podyacheva et al. Nutrients
- Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics
- (2021) Archana Adhikari et al. Pharmaceuticals
- NAD+ Metabolism and Regulation: Lessons From Yeast
- (2020) Trevor Croft et al. Biomolecules
- Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside
- (2020) Łukasz Mateuszuk et al. BIOCHEMICAL PHARMACOLOGY
- Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically‐based pharmacokinetic modeling
- (2020) Jong Bong Lee et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
- (2020) Kendall B. Wallace et al. CIRCULATION RESEARCH
- SIRT1 and aging related signaling pathways
- (2020) Cui Chen et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats
- (2020) Marina Krasnova et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
- (2020) Mario Mehmel et al. Nutrients
- Nicotinamide riboside reduces cardiometabolic risk factors and modulates cardiac oxidative stress in obese Wistar rats under caloric restriction
- (2020) Josimar Macedo de Castro et al. LIFE SCIENCES
- NAD+ metabolism and its roles in cellular processes during ageing
- (2020) Anthony J. Covarrubias et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of Smads signaling pathway
- (2019) Rui Jiang et al. LIFE SCIENCES
- Oxidative stress injury in doxorubicin-induced cardiotoxicity
- (2019) Mei Songbo et al. TOXICOLOGY LETTERS
- Gut Microbiota Shapes the Efficiency of Cancer Therapy
- (2019) Weidong Ma et al. Frontiers in Microbiology
- Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis
- (2019) Tho X. Pham et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress
- (2019) Jiamao Lin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
- (2019) Yasir S. Elhassan et al. Cell Reports
- P6274Role of the nicotinamide riboside kinase 2 in NAD metabolism in the heart in basal and pathological condition
- (2019) R Deloux et al. EUROPEAN HEART JOURNAL
- MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1
- (2019) Can Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
- (2018) Luis Rajman et al. Cell Metabolism
- NAD + Intermediates: The Biology and Therapeutic Potential of NMN and NR
- (2018) Jun Yoshino et al. Cell Metabolism
- Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
- (2018) Kaviyarasi Renu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis
- (2018) Guangliang Hong et al. FREE RADICAL BIOLOGY AND MEDICINE
- CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1
- (2018) Yu-Pei Yuan et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Update on pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
- (2018) Raphaëlle Corremans et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
- (2017) Nicolas Diguet et al. CIRCULATION
- SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy
- (2016) Donato Cappetta et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
- (2016) Samuel A. J. Trammell et al. Nature Communications
- Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer
- (2014) Yu-Wen Cao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- FOXO Transcription Factors: Their Clinical Significance and Regulation
- (2014) Yu Wang et al. Biomed Research International
- The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity
- (2012) Carles Cantó et al. Cell Metabolism
- Bacterial Inactivation of the Anticancer Drug Doxorubicin
- (2012) Erin L. Westman et al. CHEMISTRY & BIOLOGY
- SIRT1, metabolism and cancer
- (2011) John R.P. Knight et al. CURRENT OPINION IN ONCOLOGY
- Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway
- (2009) Elizabeth D. Brookins Danz et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nicotinic Acid, Nicotinamide, and Nicotinamide Riboside: A Molecular Evaluation of NAD+ Precursor Vitamins in Human Nutrition
- (2008) Katrina L Bogan et al. Annual Review of Nutrition
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now